Skip to Content

Uprima

Active Substance: apomorphine hydrochloride
Common Name: apomorphine
ATC Code: G04BE
Marketing Authorisation Holder: Abbott Laboratories Ltd.
Active Substance: apomorphine hydrochloride
Status: Withdrawn
Authorisation Date: 2001-05-28
Therapeutic Area: Erectile Dysfunction
Pharmacotherapeutic Group: Urologicals

Therapeutic Indication

Treatment of men with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.
In order for Uprima to be effective, sexual stimulation is required.

The marketing authorisation for Uprima has not been renewed by the marketing authorisation holder and is now withdrawn.

Source: European Medicines Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide